Commonwealth Equity Services
AMRX icon

Commonwealth Equity Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Commonwealth Equity Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,349
Closed -$464K – 4421
2026
Q1 		$464K Buy
+37,349
New +$501K ﹤0.01% 3275
2023
Q2 		– Sell
-13,025
Closed -$18K – 3834
2023
Q1 		$18K Buy
+13,025
New +$25.9K ﹤0.01% 3679
2020
Q2 		– Sell
-11,600
Closed -$40K – 2951
2020
Q1 		$40K Buy
+11,600
New +$49.1K ﹤0.01% 2705

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Commonwealth Equity Services's AMRX Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 37,349 shares — an estimated $464K sold.

Commonwealth Equity Services first reported a position in AMRX in Q1 2020 and held it in 3 quarters. The position peaked at $464K in Q1 2026. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Commonwealth Equity Services reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 37,349 Amneal Pharmaceuticals shares in Q2 2026, an estimated $464K.
  • Commonwealth Equity Services first reported a position in Amneal Pharmaceuticals in Q1 2020 and held it in 3 quarters.
  • Commonwealth Equity Services's Amneal Pharmaceuticals position peaked at $464K in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.